An investor in NYSEMKT:IMUC shares filed a lawsuit over alleged violations of Federal Securities Laws by ImmunoCellular Therapeutics. Investors who purchased shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff claims that between May 1, 2012 through December 11, 2013 the defendants developed […]